[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2825920B1 - Desferal comme inhibiteur de no-synthase et utilisations - Google Patents

Desferal comme inhibiteur de no-synthase et utilisations

Info

Publication number
FR2825920B1
FR2825920B1 FR0107876A FR0107876A FR2825920B1 FR 2825920 B1 FR2825920 B1 FR 2825920B1 FR 0107876 A FR0107876 A FR 0107876A FR 0107876 A FR0107876 A FR 0107876A FR 2825920 B1 FR2825920 B1 FR 2825920B1
Authority
FR
France
Prior art keywords
desferal
synthase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0107876A
Other languages
English (en)
Other versions
FR2825920A1 (fr
Inventor
Grierson Marie Madeleine Cals
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0107876A priority Critical patent/FR2825920B1/fr
Priority to PCT/FR2002/002065 priority patent/WO2002102345A2/fr
Publication of FR2825920A1 publication Critical patent/FR2825920A1/fr
Application granted granted Critical
Publication of FR2825920B1 publication Critical patent/FR2825920B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0107876A 2001-06-15 2001-06-15 Desferal comme inhibiteur de no-synthase et utilisations Expired - Fee Related FR2825920B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0107876A FR2825920B1 (fr) 2001-06-15 2001-06-15 Desferal comme inhibiteur de no-synthase et utilisations
PCT/FR2002/002065 WO2002102345A2 (fr) 2001-06-15 2002-06-14 Deferoxamine comme inhibiteur de no-synthase et utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0107876A FR2825920B1 (fr) 2001-06-15 2001-06-15 Desferal comme inhibiteur de no-synthase et utilisations

Publications (2)

Publication Number Publication Date
FR2825920A1 FR2825920A1 (fr) 2002-12-20
FR2825920B1 true FR2825920B1 (fr) 2006-04-28

Family

ID=8864372

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0107876A Expired - Fee Related FR2825920B1 (fr) 2001-06-15 2001-06-15 Desferal comme inhibiteur de no-synthase et utilisations

Country Status (2)

Country Link
FR (1) FR2825920B1 (fr)
WO (1) WO2002102345A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9737511B2 (en) * 2004-05-24 2017-08-22 Geoffrey C. GURTNER Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
US8975294B2 (en) * 2009-08-19 2015-03-10 Hadasit Medical Research Services And Development Ltd. Desferrioxamine-metal complexes for the treatment of immune-related disorders
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
US11331288B2 (en) 2017-09-14 2022-05-17 The Board Of Trustees Of The Leland Stanford Junior University Conditioning irradiated tissue for increasing vascularity
US20210315789A1 (en) * 2018-09-20 2021-10-14 Tautona Group Ip Holding Company, L.L.C. Iron chelators for treating aesthetic skin conditions
JP7412898B2 (ja) 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP2021095354A (ja) 2019-12-16 2021-06-24 ロレアル 特定の成分の組合せを含む安定な組成物
WO2023120259A1 (fr) 2021-12-20 2023-06-29 Oreal Composition stable comprenant un rétinoïde
WO2023120390A1 (fr) 2021-12-20 2023-06-29 L'oreal Composition stable comprenant un rétinoïde et un composé d'acide ascorbique
FR3131845B1 (fr) 2022-01-19 2024-11-01 Loreal Composition stable comprenant un rétinoïde
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
WO2024135424A1 (fr) 2022-12-20 2024-06-27 L'oreal Composition comprenant un complexe polyionique à base d'acide hyaluronique et un antioxydant hydrophile ou lipophile
FR3145279A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition comprenant un complexe polyionique à base d’acide hyaluronique et un antioxydant lipophile
WO2024135577A1 (fr) 2022-12-23 2024-06-27 L'oreal Composition de dispersion stable comprenant du rétinoïde
FR3145278A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition de dispersion stable comprenant un rétinoïde

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7302M (fr) * 1966-03-04 1969-09-29
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
ATE177939T1 (de) * 1987-10-22 1999-04-15 Procter & Gamble Chelatbildner enthaltende lichtschutzmittel
FR2674748B1 (fr) * 1991-04-03 1995-01-13 Oreal Utilisation de sphingolipides dans la preparation d'une composition cosmetique ou dermopharmaceutique protegeant la peau et les cheveux contre les effets nocifs de la pollution atmospherique.
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
GB9309387D0 (en) * 1993-05-06 1993-06-16 Wellcome Found Nitric oxide scavengers
AU5317296A (en) * 1995-03-24 1996-10-16 Francis V. Defeudis Methods for treating conditions associated with excess nitri c oxide
JP3911642B2 (ja) * 1995-06-06 2007-05-09 株式会社加美乃素本舗 皮膚外用剤
FR2740339B1 (fr) * 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
JPH10120557A (ja) * 1996-10-16 1998-05-12 Sekisui Chem Co Ltd 創傷治療物質
JPH10279485A (ja) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The 組成物

Also Published As

Publication number Publication date
WO2002102345A3 (fr) 2003-03-20
WO2002102345A2 (fr) 2002-12-27
FR2825920A1 (fr) 2002-12-20

Similar Documents

Publication Publication Date Title
FR2825920B1 (fr) Desferal comme inhibiteur de no-synthase et utilisations
EE200200426A (et) PDE4 isosüümide inhibiitoritena kasulikud pürimidiinkarboksamiidid
DE60033859D1 (de) Hemmer des Respiratorischen Syncytial Virus
NO20043158L (no) Substituerte kinazolinderivater som inhibitorer av aurorakinaser
EP1438068A4 (fr) Anticorps inhibiteurs de gdf-8 et utilisations associees
NO20031494D0 (no) Bestemmelse av brudd-lukningstrykk
FR09C0004I2 (fr) Pyrimidines comme inhibiteurs de reproduction du VIH
EE200300361A (et) PDE4 isosüümide inhibiitoritena kasutatavad eetriderivaadid
DE60111430D1 (de) Hypochlorige säure zusammensetzung und ihre verwendungen
EE200400048A (et) Atorvastatiinkaltsiumi kristalsed vormid VI ja VII
AU2002305396A8 (en) Use of dihydropyrazoles to increase erythropoietin and vasculari zation
NO20041968L (no) Anvendelse av cystationin
PT1429926E (pt) Circuito de interligacao
FR2810037B1 (fr) Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible
DE60031450D1 (de) Polymorph v von torasemid
SE0302361L (sv) Inhibering av upptagning av monoamin
FR2825921B1 (fr) Inhibiteur de no-synthase et utilisations
ATE331956T1 (de) Nachweis von entzündungen
FR2825922B1 (fr) 2-hexadecanoate d'ascorbyle comme inhibiteur de no-synthase et utilisations
FR2825923B1 (fr) Inhibiteur de no-synthase et utilisations
DE60124397D1 (de) Inhibitoren von serinproteasen
FR2819255B1 (fr) Derives chimiques et leur application comme agent antitelomerase
FR2832151B1 (fr) Utilisation de derives de 2-amino-4-heteroarylethyl-thiazoline comme inhibiteurs de no-synthase inductible
FR2832150B1 (fr) Utilisation de derives de 2-amino-4-pyridylmethyl-thiazoline comme inhibiteurs de no-synthase inductible
DE50203046D1 (de) Verwendung von Esterquats

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080229